These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 35311986)
1. Perceptions of the health risks of cannabis: estimates from national surveys in Canada and the United States, 2018-2019. Goodman S; Hammond D Health Educ Res; 2022 Mar; 37(2):61-78. PubMed ID: 35311986 [TBL] [Abstract][Full Text] [Related]
2. Trends in the use of cannabis products in Canada and the USA, 2018 - 2020: Findings from the International Cannabis Policy Study. Hammond D; Goodman S; Wadsworth E; Freeman TP; Kilmer B; Schauer G; Pacula RL; Hall W Int J Drug Policy; 2022 Jul; 105():103716. PubMed ID: 35613480 [TBL] [Abstract][Full Text] [Related]
3. International differences in patterns of cannabis use among youth: Prevalence, perceptions of harm, and driving under the influence in Canada, England & United States. Wadsworth E; Hammond D Addict Behav; 2019 Mar; 90():171-175. PubMed ID: 30412908 [TBL] [Abstract][Full Text] [Related]
4. Trends and Socio-Demographic Differences of Cannabis Vaping in the USA and Canada. Lim CCW; Chan GCK; Wadsworth E; Stjepanović D; Chiu V; Chung JYC; Sun T; Connor J; Leung J; Gartner C; Hall W; Hammond D Int J Environ Res Public Health; 2022 Nov; 19(21):. PubMed ID: 36361272 [TBL] [Abstract][Full Text] [Related]
5. Prevalence and forms of cannabis use in legal vs. illegal recreational cannabis markets. Goodman S; Wadsworth E; Leos-Toro C; Hammond D; Int J Drug Policy; 2020 Feb; 76():102658. PubMed ID: 31927413 [TBL] [Abstract][Full Text] [Related]
6. Co-use of cannabis and alcohol before and after Canada legalized nonmedical cannabis: A repeat cross-sectional study. Hobin E; Weerasinghe A; Boniface S; Englund A; Wadsworth E; Hammond D J Psychopharmacol; 2023 May; 37(5):462-471. PubMed ID: 37039435 [TBL] [Abstract][Full Text] [Related]
7. Noticing of cannabis health warning labels in Canada and the US. Goodman S; Hammond D Health Promot Chronic Dis Prev Can; 2021; 41(7-8):201-210. PubMed ID: 34427418 [TBL] [Abstract][Full Text] [Related]
8. Perceptions of cannabis use risk to mental health among youth in Canada, England and the United States from 2017 to 2021. Lemos MK; Taylor E; Wadsworth E; Reid JL; Hammond D; East K Drug Alcohol Depend; 2023 Sep; 250():110904. PubMed ID: 37549543 [TBL] [Abstract][Full Text] [Related]
9. Do Mandatory Health Warning Labels on Consumer Products Increase Recall of the Health Risks of Cannabis? Goodman S; Leos-Toro C; Hammond D Subst Use Misuse; 2022; 57(4):569-580. PubMed ID: 34989662 [TBL] [Abstract][Full Text] [Related]
10. Differences in patterns of cannabis use among youth: Prevalence, perceptions of harm and driving under the influence in the USA where non-medical cannabis markets have been established, proposed and prohibited. Wadsworth E; Hammond D Drug Alcohol Rev; 2018 Nov; 37(7):903-911. PubMed ID: 29992695 [TBL] [Abstract][Full Text] [Related]
11. Cannabis health knowledge and risk perceptions among Canadian youth and young adults. Leos-Toro C; Fong GT; Meyer SB; Hammond D Harm Reduct J; 2020 Aug; 17(1):54. PubMed ID: 32746859 [TBL] [Abstract][Full Text] [Related]
12. Prevalence and modes of cannabis use among youth in Canada, England, and the US, 2017 to 2019. Hammond D; Wadsworth E; Reid JL; Burkhalter R Drug Alcohol Depend; 2021 Feb; 219():108505. PubMed ID: 33421799 [TBL] [Abstract][Full Text] [Related]
13. Co-Use, Simultaneous Use, and Mixing of Cannabis and Tobacco: A Cross-National Comparison of Canada and the US by Cannabis Administration Type. Chu A; Chaiton M; Kaufman P; Goodwin RD; Lin J; Hindocha C; Goodman S; Hammond D Int J Environ Res Public Health; 2023 Feb; 20(5):. PubMed ID: 36901216 [TBL] [Abstract][Full Text] [Related]
14. Does Unit-Dose Packaging Influence Understanding of Serving Size Information for Cannabis Edibles? Goodman S; Hammond D J Stud Alcohol Drugs; 2020 Mar; 81(2):173-179. PubMed ID: 32359046 [TBL] [Abstract][Full Text] [Related]
15. Cannabis advertising, promotion and branding: Differences in consumer exposure between 'legal' and 'illegal' markets in Canada and the US. Rup J; Goodman S; Hammond D Prev Med; 2020 Feb; 133():106013. PubMed ID: 32027914 [TBL] [Abstract][Full Text] [Related]
16. Cannabis use for symptom relief in multiple sclerosis: A cross-sectional survey of webinar attendees in the US and Canada. Hildebrand A; Minnier J; Cameron MH Mult Scler Relat Disord; 2020 Feb; 38():101516. PubMed ID: 31855842 [TBL] [Abstract][Full Text] [Related]
17. Evaluating the impacts of cannabis legalization: The International Cannabis Policy Study. Hammond D; Goodman S; Wadsworth E; Rynard V; Boudreau C; Hall W Int J Drug Policy; 2020 Feb; 77():102698. PubMed ID: 32113149 [TBL] [Abstract][Full Text] [Related]
18. Perceptions of effectiveness and believability of pictorial and text-only health warning labels for cannabis products among Canadian youth. Leos-Toro C; Fong GT; Meyer SB; Hammond D Int J Drug Policy; 2019 Nov; 73():24-31. PubMed ID: 31336290 [TBL] [Abstract][Full Text] [Related]
19. Prevalence and self-reported reasons of cannabis use for medical purposes in USA and Canada. Leung J; Chan G; Stjepanović D; Chung JYC; Hall W; Hammond D Psychopharmacology (Berl); 2022 May; 239(5):1509-1519. PubMed ID: 35020045 [TBL] [Abstract][Full Text] [Related]
20. Consumer perceptions of legal cannabis products in Canada, 2019-2021: a repeat cross-sectional study. Wadsworth E; Fataar F; Goodman S; Smith DM; Renard J; Gabrys R; Jesseman R; Hammond D BMC Public Health; 2022 Nov; 22(1):2048. PubMed ID: 36348479 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]